Focus Partners Advisor Solutions LLC bought a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,142 shares of the company's stock, valued at approximately $998,000.
A number of other institutional investors and hedge funds have also bought and sold shares of CHE. Monetary Solutions Ltd bought a new position in shares of Chemed during the fourth quarter valued at $25,000. Los Angeles Capital Management LLC acquired a new stake in Chemed in the fourth quarter valued at $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed during the 4th quarter worth $27,000. Versant Capital Management Inc lifted its holdings in Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after buying an additional 75 shares during the period. Finally, Global Retirement Partners LLC lifted its holdings in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock worth $37,000 after buying an additional 58 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on CHE shares. Royal Bank Of Canada raised their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a report on Thursday, July 30th. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. Bank of America reissued a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Oppenheimer raised their target price on Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. Finally, Wall Street Zen raised Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $530.75.
View Our Latest Stock Report on Chemed
Chemed Trading Up 0.2%
Shares of Chemed stock opened at $533.83 on Monday. The company has a market capitalization of $6.98 billion, a P/E ratio of 26.81, a price-to-earnings-growth ratio of 2.02 and a beta of 0.51. The stock has a fifty day simple moving average of $489.13 and a 200 day simple moving average of $442.95. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.
Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. During the same period last year, the business earned $4.27 EPS. The business's revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, sell-side analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.
Chemed Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be issued a $0.70 dividend. This is a boost from Chemed's previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. Chemed's dividend payout ratio is currently 12.05%.
Insider Activity at Chemed
In related news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 3,537 shares of company stock valued at $1,782,654. 3.33% of the stock is owned by insiders.
Chemed Company Profile
(
Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.